Implications of cardiac markers in risk-stratification and management for COVID-19 patients

Li, PP; Wu, W; Zhang, TT; Wang, ZY; Li, J; Zhu, MY; Liang, Y; You, WH; Li, KN; Ding, R; Huang, B; Wu, LX; Duan, WW; Han, Y; Li, XS; Tang, X; Wang, X; Shen, H; Wang, QH; Yan, H; Xia, XY; Ji, Y; Chen, HS

Ji, Y; Chen, HS (corresponding author), Nanjing Med Univ, Sch Pharm, Key Lab Cardiovasc & Cerebrovasc Med, Nanjing, Peoples R China.; Ji, Y; Chen, HS (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Cardiovascular Dis Transla, Key Lab Targeted Intervent Cardiovasc Dis, Nanjing, Peoples R China.; Yan, H (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Lab Med Ctr, Nanjing, Peoples R China.; Xia, XY (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab M

CRITICAL CARE, 2021; 25 (1):

Abstract

Background COVID-19 has resulted in high mortality worldwide. Information regarding cardiac markers for precise risk-stratification is limited. We aim......

Full Text Link